|
1
|
Fialkow PJ, Thomas ED, Bryant JI and
Neiman PE: Leukaemic transformation of engrafted human marrow cells
in vivo. Lancet. 1:251–255. 1971.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sala-Torra O, Hanna C, Loken MR, Flowers
ME, Maris M, Ladne PA, Mason JR, Senitzer D, Rodriguez R, Forman
SJ, et al: Evidence of donor-derived hematologic malignancies after
hematopoietic stem cell transplantation. Biol Blood Marrow
Transplant. 12:511–517. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hertenstein B, Hambach L, Bacigalupo A,
Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A,
Schwertfeger R, et al: Development of leukemia in donor cells after
allogeneic stem cell transplantation-a survey of the European group
for blood and marrow transplantation (EBMT). Haematologica.
90:969–975. 2005.PubMed/NCBI
|
|
4
|
Boyd CN, Ramberg RC and Thomas ED: The
incidence of recurrence of leukemia in donor cells after allogeneic
bone marrow transplantation. Leuk Res. 6:833–837. 1982.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ballen KK, Cutler C, Yeap BY, McAfee SL,
Dey BR, Attar EC, Chen YB, Haspel RL, Liney D, Koreth J, et al:
Donor-derived second hematologic malignancies after cord blood
transplantation. Biol Blood Marrow Transplant. 16:1025–1031.
2010.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kato M, Yamashita T, Suzuki R, Matsumoto
K, Nishimori H, Takahashi S, Iwato K, Nakaseko C, Kondo T, Imada K,
et al: Donor cell-derived hematological malignancy: A survey by the
Japan society for hematopoietic cell transplantation. Leukemia.
30:1742–1745. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wiseman DH: Donor cell leukemia: A review.
Biol Blood Marrow Transplant. 17:771–789. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gondek LP, Zheng G, Ghiaur G, DeZern AE,
Matsui W, Yegnasubramanian S, Lin MT, Levis M, Eshleman JR,
Varadhan R, et al: Donor cell leukemia arising from clonal
hematopoiesis after bone marrow transplantation. Leukemia.
30:1916–1920. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Dietz AC, DeFor TE, Brunstein CG and
Wagner JE Jr: Donor-derived myelodysplastic syndrome and acute
leukaemia after allogeneic haematopoietic stem cell
transplantation: Incidence, natural history and treatment response.
Br J Haematol. 166:209–212. 2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Murata M, Ishikawa Y, Ohashi H, Terakura
S, Ozeki K, Kiyoi H and Naoe T: Donor cell leukemia after
allogeneic peripheral blood stem cell transplantation: A case
report and literature review. Int J Hematol. 88:111–115.
2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Reichard KK, Zhang QY, Sanchez L, Hozier
J, Viswanatha D and Foucar K: Acute myeloid leukemia of donor
origin after allogeneic bone marrow transplantation for precursor
T-cell acute lymphoblastic leukemia: Case report and review of the
literature. Am J Hematol. 81:178–185. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Fraser CJ, Hirsch BA, Dayton V, Creer MH,
Neglia JP, Wagner JE and Baker KS: First report of donor
cell-derived acute leukemia as a complication of umbilical cord
blood transplantation. Blood. 106:4377–4380. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ando T, Yujiri T, Mitani N, Takeuchi H,
Nomiyama J, Suguchi M, Matsubara A and Tanizawa Y: Donor
cell-derived acute myeloid leukemia after unrelated umbilical cord
blood transplantation. Leukemia. 20:744–745. 2006.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Matsunaga T, Murase K, Yoshida M, Fujimi
A, Iyama S, Kuribayashi K, Sato T, Kogawa K, Hirayama Y, Sakamaki
S, et al: Donor cell derived acute myeloid leukemia after
allogeneic cord blood transplantation in a patient with adult
T-cell lymphoma. Am J Hematol. 79:294–298. 2005.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Engel N, Rovo A, Badoglio M, Labopin M,
Basak GW, Beguin Y, Guyotat D, Ljungman P, Nagler A, Schattenberg
A, et al: European experience and risk factor analysis of donor
cell-derived leukaemias/MDS following haematopoietic cell
transplantation. Leukemia. 33:508–517. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dickson MA, Papadopoulos EB, Hedvat CV,
Jhanwar SC and Brentjens RJ: Acute myeloid leukemia arising from a
donor derived premalignant hematopoietic clone: A possible
mechanism for the origin of leukemia in donor cells. Leuk Res Rep.
3:38–41. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wynn RF, Cross MA, Hatton C, Will AM,
Lashford LS, Dexter TM and Testa NG: Accelerated telomere
shortening in young recipients of allogeneic bone-marrow
transplants. Lancet. 351:178–181. 1998.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Flynn CM and Kaufman DS: Donor cell
leukemia: Insight into cancer stem cells and the stem cell niche.
Blood. 109:2688–2692. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Suárez-González J, Martínez-Laperche C,
Kwon M, Balsalobre P, Carbonell D, Chicano M, Rodríguez-Macías G,
Serrano D, Gayoso J, Díez-Martín JL and Buño I: Donor cell-derived
hematologic neoplasms after hematopoietic stem cell
transplantation: A systematic review. Biol Blood Marrow Transplant.
24:1505–1513. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Berger R and Bernard OA: Jumping
translocations. Genes Chromosomes Cancer. 46:717–723.
2007.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shaffer LG, McGowan-Jordan J and Schmid M
(eds): ISCN 2013: An international system for human cytogenetic
nomenclature. Karger 140, 2013.
|
|
22
|
Yeung CCS, Deeg HJ, Pritchard C, Wu D and
Fang M: Jumping translocations in myelodysplastic syndromes. Cancer
Genet. 209:395–402. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Couture T, Amato K, DiAdamo A and Li P:
Jumping translocations of 1q in myelodysplastic syndrome and acute
myeloid leukemia: Report of three cases and review of literature.
Case Rep Genet. 2018(8296478)2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sanford D, DiNardo CD, Tang G, Cortes JE,
Verstovsek S, Jabbour E, Ravandi F, Kantarjian H and Garcia-Manero
G: Jumping translocations in myeloid malignancies associated with
treatment resistance and poor survival. Clin Lymphoma Myeloma Leuk.
15:556–562. 2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Flicek P, Amode MR, Barrell D, Beal K,
Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G,
Fitzgerald S, et al: Ensembl 2014. Nucleic Acids Res. 42 (Database
Issue):D749–D755. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cingolani P, Platts A, Wang le L, Coon M,
Nguyen T, Wang L, Land SJ, Lu X and Ruden DM: A program for
annotating and predicting the effects of single nucleotide
polymorphisms, SnpEff: SNPs in the genome of Drosophila
melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 6:80–92.
2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Sevilla J, Querol S, Molines A,
González-Vicent M, Balas A, Carrió A, Estella J, Angel Díaz M and
Madero L: Transient donor cell-derived myelodysplastic syndrome
with monosomy 7 after unrelated cord blood transplantation. Eur J
Haematol. 77:259–263. 2006.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mitsui H, Nakazawa T, Tanimura A, Karasuno
T and Hiraoka A: Donor cell-derived chronic myeloproliferative
disease with t(7;11)(p15;p15) after cord blood transplantation in a
patient with Philadelphia chromosome-positive acute lymphoblastic
leukemia. Int J Hematol. 86:192–195. 2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nagamura-Inoue T, Kodo H, Takahashi TA,
Mugishima H, Tojo A and Asano S: Four cases of donor cell-derived
AML following unrelated cord blood transplantation for adult
patients: Experiences of the Tokyo cord blood bank. Cytotherapy.
9:727–728. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Iwato K, Katayama Y, Nagoshi H, Ota I,
Yuasa H, Asaoku H and Kyo T: Donor cell derived AML after cord
blood transplantation in a patient with refractory all. Jpn J Clin
Hematol. 48(1168)2007.
|
|
31
|
Hamaki T, Kajiwara K, Kami M, Murashige N,
Funaki M, Harima A, Kogure K, Yamada K, Kodo H and Kouzai Y: Donor
cell-derived acute monoblastic leukemia involving MLL gene
translocation in an adult patient who received umbilical cord blood
transplantation. Bone Marrow Transplant. 41:91–92. 2008.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Konuma T, Ooi J, Takahashi S, Tomonari A,
Tsukada N, Kato S, Sato A, Monma F, Hongo E, Uchimaru K, et al:
Donor cell derived myelodysplastic syndrome after cord blood
transplantation. Bone Marrow Transplant. 43:429–431.
2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ohnaka T, Yonezawa S and Imada K: A case
of donor cell leukemia following cord blood transplantation for
recurrent follicular lymphoma underwent second cord blood
transplantation. The 31st Annual Meeting of the Japan society for
Hematopoietic Cell Transplantation. 2009;186: (abstract in
Japanese). https://www.jshct.com/modules/basicauth2/index.php?file=jshctam31.pdf.
|
|
34
|
Castleton AZ, Brazma D, Howard-Reeves J,
Chanalaris A, Glanville J, Nizetic D, Chakraverty R and Nacheva EP:
Genome gains at chromosome 21q21/22 segment leads to
co-amplification of down syndrome critical regions and known
oncogenes in a case of donor cell-derived acute myeloid leukemia
following allogeneic sex mismatched umbilical cord blood
transplantation for chronic myeloid leukemia. Br J Haematol.
151:285–288. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Crow J, Youens K, Michalowski S, Perrine
G, Emhart C, Johnson F, Gerling A, Kurtzberg J, Goodman BK,
Sebastian S, et al: Donor cell leukemia in umbilical cord blood
transplant patients: A case study and literature review
highlighting the importance of molecular engraftment analysis. J
Mol Diag. 12:530–537. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Shono Y, Kosugi-Kanaya M, Shiratori S,
Sugita J, Fujimoto K, Kondo T, Nishio M, Tanaka J and Imamura M:
Donor cell leukemia after umbilical cord blood transplantation:
Recurrent or de novo? The importance of diagnosis for therapeutic
decision making. Int J Hematol. 93:563–565. 2011.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Yoshida M, Takemura R, Kosugi M, Shiratori
S, Shono Y, Takeda M, Sugita J, Fujimoto K, Nishio M, et al: Donor
cell leukemia after umbilical cord blood transplantation. Jpn J
Clin Hematol. 52(1241)2011. View Article : Google Scholar
|
|
38
|
Gustafsson B, Moell J, LeBlanc K, Barbany
G, Söderhäll S and Winiarski J: Donor cell-derived acute myeloid
leukemia after second allogenic cord blood transplantation in a
patient with Fanconi anemia. Pediatr Transplant. 16:E241–E245.
2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Yamazaki R, Nakasone H, Wada H, Sakamoto
K, Ashizawa M, Sato M, Terasako K, Kikuchi M, Kimura S, Okuda S, et
al: Recurrence of monoclonal gammopathy associated with
donor-derived myelodysplastic syndrome after cord blood stem cell
transplantation. Exp Hematol. 39:1119–1123. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang E, Hutchinson CB, Huang Q, Lu CM,
Crow J, Wang FF, Sebastian S, Rehder C, Lagoo A, Horwitz M, et al:
Donor cell-derived leukemias/myelodysplastic neoplasms in
allogeneic hematopoietic stem cell transplant recipients. A
clinicopathologic study of 10 cases and a comprehensive review of
the literature. Am J Clin Pathol. 135:525–540. 2011.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Cotter R, Najfeld V, Isola L, Toro GD,
Roman E, Peterson B and Mascarenhas J: An unusual case of
donor-derived myelodysplastic syndrome following double-unit
umbilical cord blood transplantation in acute lymphoblastic
leukemia. Am J Hematol. 9:931–933. 2012.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Chonabayashi K, Kondo T, Yamamoto K,
Tanaka Y, Nagai Y, Hishizawa M and Takaori-Kondo A: Successful use
of second cord blood transplantation to achieve long-term remission
in cord blood donor cell-derived AML harboring a FLT3-ITD and an
NPM1 mutation. Bone Marrow Transplant. 47:1252–1253.
2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sugimori C, Yoshida A, Munemoto S, Zaimoku
Y, Sawazaki A, Yamaguchi M and Ueda M: Donor-type myelodysplastic
syndrome after cord blood transplant in a patient with aplastic
anemia. Jpn J Clin Hematol. 53(1277)2012.
|
|
44
|
Rodríguez-Macías G, Martínez-Laperche C,
Gayoso J, Noriega V, Serrano D, Balsalobre P, Muñoz-Martínez C,
Díez-Martín JL and Buño I: Mutation of the NPM1 gene contributes to
the development of donor cell-derived acute myeloid leukemia after
unrelated cord blood transplantation for acute lymphoblastic
leukemia. Human Pathol. 44:1696–1699. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hamahata K, Kotani S, Oka S, Ukyo N,
Watanabe N and Nogawa M: Development of donor cell leukemia
mimicking hematogones after unrelated cord blood transplantation
for relapsed acute lymphoblastic leukemia. Rinsho Ketsueki.
54:473–477. 2013.(In Japanese). PubMed/NCBI View Article : Google Scholar
|
|
46
|
Shiozaki H, Yoshinaga K, Kondo T, Imai Y,
Shiseki M, Mori N, Teramura M and Motoji T: Donor cell-derived
leukemia after cord blood transplantation and a review of the
literature: Differences between cord blood and BM as the transplant
source. Bone Marrow Transplant. 49:102–109. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hirsch P, Mamez AC, Belhocine R, Lapusan
S, Tang R, Suner L, Bories D, Marzac C, Fava F, Legrand O, et al:
Clonal history of a cord blood donor cell leukemia with prenatal
somatic JAK2 V617F mutation. Leukemia. 30:1756–1759.
2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Suárez-González J, Martínez-Laperche C,
Martínez N, Rodríguez-Macías G, Kwon M, Balsalobre P, Carbonell D,
Chicano M, Serrano D, Triviño JC, et al: Whole-exome sequencing
reveals acquisition of mutations leading to the onset of donor cell
leukemia after hematopoietic transplantation: A model of
leukemogenesis. Leukemia. 32:1822–1826. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Ketterl TG, Wu D, Fromm JR, Soma L,
Dahlberg AE, Wood BL and Tarlock K: Donor derived T-cell large
granular lymphocyte leukemia after cord blood transplant for
pediatric T-cell lymphoblastic leukemia. Bone Marrow Transplant.
53:352–355. 2018.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Adachi Y, Yamaguchi Y, Sagou K, Yamaga Y,
Fukushima N, Ozeki K and Kohno A: Acute megakaryoblastic leukemia
developing as donor cell leukemia after umbilical cord blood
transplantation. Intern Med. 57:569–574. 2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Ikegawa S, Najima Y, Sano N, Horiguchi SI,
Kaito S, Kurosawa S, Sakaguchi M, Harada K, Hino Y, Yamamoto K, et
al: Donor cell leukemia with bone marrow necrosis. Rinsho Ketsueki.
57:2334–2338. 2016.(In Japanese). PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hayes C, Petersen B and Malone A: Donor
cell myeloid sarcoma in an umbilical cord transplant patient: A
case report and a review of the literature. Case Rep Hematol.
2015(186869)2015.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Scopim-Ribeiro R, Machado-Neto JA, Campos
Pde M, Silva CA, Favaro P, Lorand-Metze I, Costa FF, Saad ST and
Traina F: Ten-eleven-translocation 2 (TET2) is downregulated in
myelodysplastic syndromes. Eur J Haematol. 94:413–418.
2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhang W, Shao ZH, Fu R, Wang HQ, Li LJ,
Wang J, Qu W, Liang Y, Wang GJ, Wang XM, et al: TET2 expression in
bone marrow mononuclear cells of patients with myelodysplastic
syndromes and its clinical significances. Cancer Biol Med. 9:34–37.
2012.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Bejar R, Lord A, Stevenson K, Bar-Natan M,
Pérez-Ladaga A, Zaneveld J, Wang H, Caughey B, Stojanov P, Getz G,
et al: TET2 mutations predict response to hypomethylating agents in
myelodysplastic syndrome patients. Blood. 124:2705–2712.
2014.PubMed/NCBI View Article : Google Scholar
|
